The Primary
Care Companionfor CNS Disorders

Primary Care

Editorial February 27, 2020

Many Thanks

Larry Culpepper, MD, MPH

Prim Care Companion CNS Disord 2020;22(1):20ed02604

Article Abstract

Continue Reading...

Did you know members enjoy unlimited free PDF downloads as part of their subscription? Subscribe today for instant access to this article and our entire library in your preferred format. Alternatively, you can purchase the PDF of this article individually.

Subscribe Now

Already a member? Login

Purchase PDF for $40.00

Members enjoy free PDF downloads on all articles. Join today

Purchase PDF for $40.00

Members enjoy free PDF downloads on all articles. Join today

Save Save

Cite

Advertisement
GAM ID: sidebar-top

INFORMATION FROM INDUSTRY

AUVELITY is an FDA-approved treatment for adults with MDD. Auvelity, is a rapid-acting antidepressant with a multimodal mechanism, targeting both glutamatergic and monoaminergic pathways. Learn more about how AUVELITY is thought to work and side effects. Please see Important Safety Information within this document and the full Prescribing Information.

Advertisement
GAM ID: sidebar-bottom

Vol 26 • 2024 • Number 4

Read the Current Issue

Narrative Review

Management of ADHD in Adolescents and Young Adults

Narrative Review

Tech Gaming Designs, Neurodevelopmental Vulnerabilities, and Internet Gaming Disorder Risk

Original Research

Presentation and Outcome of MCI

Original Research

Dementia Mortality Patterns in the United States

Rounds in the General Hospital

Pharmacologic Management of TBI

Rounds in the General Hospital

Evaluation and Management of Treatment-Resistant Schizophrenia

View current Issue

Related Articles

Focus on Women’s Mental Health: Twenty Years and Counting

Editorial

Focus on Women’s Mental Health: Twenty Years and Counting

June 17, 2024

On the anniversary of JCP’s Focus on Women’s Mental Health section, Marlene P. Freeman reflects on the past 20 years in women’s mental health care, including what has changed...

Marlene P. Freeman

A Welcome Focus on Psychotherapy

Editorial

A Welcome Focus on Psychotherapy

May 23, 2024

Learn more about JCP’s Focus on Psychotherapy section and meet the section editors.

John C. Markowitz, Rachel C. Vanderkruik

Truth: Keeping Us on Track in Scientific Publishing

Editorial

Truth: Keeping Us on Track in Scientific Publishing

February 5, 2024

Editor-in-Chief Marlene P. Freeman, MD, reflects on the importance of peer-reviewed research in today’s world and recognizes the contributions of JCP authors and peer reviewers over the past year.

Marlene P. Freeman